Outset Medical is a healthcare technology company focused on making dialysis more accessible and efficient for patients, providers, and health systems. Its flagship product, the Tablo Hemodialysis System, is an all-in-one device designed for acute and chronic dialysis in healthcare facilities and the home. Tablo supports several treatment types, including intermittent hemodialysis, sustained low-efficiency dialysis, prolonged intermittent renal replacement therapy, and isolated ultrafiltration. The system is designed to cover many dialysis needs without requiring additional infrastructure.

For hospitals, Outset helps organizations insource acute dialysis services through implementation guidance, staff training, and ongoing support. Its Outset Connect platform provides two-way cloud communication, automated documentation, system management, analytics, and electronic medical record integration. The company also shares clinical evidence and case studies to help healthcare teams assess its approach. For people considering home dialysis, Outset provides educational resources on kidney health and treatment options. Tablo treatments require a physician’s prescription and oversight by a trained, competent individual; the system is not indicated for continuous renal replacement therapy.